genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
GEN Edge
Close to the Edge
Close to the Edge
Close to the Edge
Front Row
GEN Edge Live
The State of Biotech
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Drug Discovery
What’s in Store for 2024? Three CEOs Look Ahead and Look Back on “Close to the Edge”
Close to the Edge
Space Race: 10x CEO Serge Saxonov Discusses Single Cell and Spatial Biology on “Close to the Edge”
Close to the Edge
Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning
Close to the Edge
BIO CEO Rachel King Outlines Industry’s Challenges on “Close to the Edge”
Close to the Edge
Carl Icahn States His Case for Change at Illumina on “Close to the Edge”
Close to the Edge
Search and Replace: Andrew Anzalone Details How Genome Editing Went Prime...
Decoding Genomic Diversity with deCODE Genetics CEO Kári Stefánsson on “Close...
Close to the Edge
From Knowledge, Drug Power: Andrew Hopkins Discusses AI-Based Development on “Close...
Shehnaaz Suliman, MD, MPhil, Discusses Targeted Respiratory Therapies on “Close to...
Helen Sabzevari, PhD, of Precigen Connects Cancer and the Immune System...
George Church, PhD, Recounts Decades of Research, 38 Companies on “Close...
Eric Ostertag, MD, PhD, Recounts His Journey from Penn Grad to...
From IT to Biotech: Sujal Patel Discusses the Promise of the...
Close to the Edge
Running Up That Hill: Nessan Bermingham on Close to the Edge
Close to the Edge
Hearing Aid: Decibel Therapeutics CEO Laurence Reid Talks to Close to...
1
2
Page 1 of 2
Scroll Up
